Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 22 of 104, showing 5 Applications out of 518 total, starting on record 106, ending on 110

# Protocol No Study Title Investigator(s) & Site(s)

106.

ECCT/17/11/01   MTN 034
    MTN 034   A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population   
Principal Investigator(s)
1. ESTHER MUMBI MAKANGA
Site(s) in Kenya
KISUMU CRS
 
View

107.

ECCT/17/05/01   Multicenter Study of the Accuracy of the BD MAXâ„¢MDR-TB Assay
    Multicenter Study of the Accuracy of the BD MAX™MDR-TB Assay for Detection of M. tuberculosis Complex and Mutations Associated with Resistance to Rifampin or Isoniazid   
Principal Investigator(s)
1. SAMUEL GURRION OUMA
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITIUTE
 
View

108.

ECCT/21/03/06   P2026
    Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum   
Principal Investigator(s)
1. Dr. Lucy Chepkurui Koech
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT CLINICAL RESEARCH CENTER
 
View

109.

ECCT/17/05/03   TDF IVR-002 Study
    Phase 1 Safety and Pharmacokinetic Study of a Polyurethane Tenofovir Disoproxil Fumarate Vaginal Ring in Sexually Active Women (TDF IVR-002)   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Partners in Health Research & Development (Thika Partners Clinical Trial Site)
 
View

110.

ECCT/24/07/03   RVF003 Trial
    Phase 2 trial to assess the immunogenicity and safety of the ChAdOx1 RVF vaccine against Rift Valley fever in adults in Kenya        
Principal Investigator(s)
1. George Warimwe
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme
 
View